Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Bates

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Nature Microbiology|January 31, 2017
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirusXiaolin Wen, Jarrod J Mousa, John T Bates, et al.
Virology|April 15, 2014
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion proteinJohn T Bates, Christopher J Keefer, James C Slaughter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2013
Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potencyJohn T Bates, Christopher J Keefer, Thomas J Utley, et al.
Scientific Reports|November 6, 2020
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoproteinRitesh Tandon, Dipanwita Mitra, Poonam Sharma, et al.
Frontiers in Molecular Biosciences|September 1, 2022
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variantsAdrianne L Gelbach, Fuming Zhang, Seok-Joon Kwon, et al.
Vaccine|June 7, 2015
Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20Amy Galliher-Beckley, Xiangdong Li, John T Bates, et al.
Vaccines|April 23, 2022
IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and ObesityJohn T Bates, Andrew P Farmer, Michael A Bierdeman, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide PolysulfateFuming Zhang, Peng He, Andre L Rodrigues, et al.
Marine Drugs|December 23, 2021
Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from <i>Monostroma nitidum</i>Yuefan Song, Peng He, Andre L Rodrigues, et al.
Annals of Pediatric Endocrinology & Metabolism|June 10, 2024
New-onset diabetes in children during the COVID-19 Pandemic: an assessment of biomarkers and psychosocial risk factors at play in MississippiJosephine Stout, Naznin Dixit, Simeen Pasha, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Nature Microbiology|January 31, 2017
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirusXiaolin Wen, Jarrod J Mousa, John T Bates, et al.
Virology|April 15, 2014
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion proteinJohn T Bates, Christopher J Keefer, James C Slaughter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 5, 2013
Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potencyJohn T Bates, Christopher J Keefer, Thomas J Utley, et al.
Scientific Reports|November 6, 2020
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoproteinRitesh Tandon, Dipanwita Mitra, Poonam Sharma, et al.
Frontiers in Molecular Biosciences|September 1, 2022
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variantsAdrianne L Gelbach, Fuming Zhang, Seok-Joon Kwon, et al.
Vaccine|June 7, 2015
Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20Amy Galliher-Beckley, Xiangdong Li, John T Bates, et al.
Vaccines|April 23, 2022
IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and ObesityJohn T Bates, Andrew P Farmer, Michael A Bierdeman, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide PolysulfateFuming Zhang, Peng He, Andre L Rodrigues, et al.
Marine Drugs|December 23, 2021
Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from <i>Monostroma nitidum</i>Yuefan Song, Peng He, Andre L Rodrigues, et al.
Annals of Pediatric Endocrinology & Metabolism|June 10, 2024
New-onset diabetes in children during the COVID-19 Pandemic: an assessment of biomarkers and psychosocial risk factors at play in MississippiJosephine Stout, Naznin Dixit, Simeen Pasha, et al.
Pageof 4